Authors: Asadabadi, Ebrahim Barzegari
Chupani, Latifeh
Jamalan, Mostafa
Mirzaie, Sako
Shahverdi, Ahmad Reza
Title: Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation
Other Titles: a computational approach in drug design
Language (ISO): en
Abstract: Inhibition of aromatase (CYTP450) as a key enzyme in the estrogen biosynthesis could result in regression of estrogen-dependent tumors and even preventing the promotion of breast cancer. Although today potent steroid and non-steroid inhibitors of aromatase are available, isoflavanone derivatives as natural compounds with least side effects have been described as the candidate for a new generation of aromatase inhibitors. 2a as an isoflavanone derivative is the most potent inhibitor of aromatase, synthesized by Bonfield et al. (2012). In our computational study, the mentioned compound was used as the template for virtual screening. Between 286 selected compounds with 70 % of structural similarity to 2a, 150 of them showed lower docking energy in comparison with 2a. Compound 2a_1 with 11.2 kcal/mol had the lowest docking energy. Interaction of 2a_1 with aromatase was further investigated and compared with 2a and androstenedione (ASD) as a natural substrate of aromatase, through 20 ns of molecular dynamic simulation. Analysis of trajectories showed, while ASD interacts with aromatase through hydrogen bonds and 2a just interacts via hydrophobic forces, 2a_1 not only accommodates in the hydrophobic active site of aromatase in a suitable manner but it also makes a stable coordination with iron atom of aromatase heme group via OB.
Subject Headings: androstenedione
aromatase inhibitor
structural-based virtual screening
Issue Date: 2013-05-23
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Jamalan_11032013_proof.pdfDNB1.31 MBAdobe PDFView/Open

This item is protected by original copyright

Items in Eldorado are protected by copyright, with all rights reserved, unless otherwise indicated.